Position in PFE
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$1,947,493
-$329,597 QoQ
Shares Held
80,876
-0.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.76%
of 13F equity value
Holder Rank
#978
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Atlas Brown,Inc. holds $23,716,828 across 9 Drug Manufacturers - General names. PFE ranks #5 (8.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
32,094 | $8,150,913 | |
| 2 | ABBV |
AbbVie Inc.
|
30,004 | $7,550,205 | |
| 3 | LLY |
ELI LILLY & Co
|
2,009 | $2,409,654 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,181 | $2,079,258 | |
| 5 | PFE |
Pfizer Inc
This page
|
80,876 | $1,947,493 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
13,373 | $770,551 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
3,508 | $443,200 | |
| 8 | GSK |
GSK plc
|
4,053 | $212,458 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,947,493 | 80,876 | Shares | Defined | 2026-07-09 | |
| 2026-03-31 | $2,277,090 | 81,093 | Shares | Defined | 2026-04-17 | |
| 2025-12-31 | $2,005,121 | 80,527 | Shares | Defined | 2026-01-09 | |
| 2025-09-30 | $1,999,415 | 78,470 | Shares | Defined | 2025-10-17 | |
| 2025-06-30 | $1,932,703 | 79,732 | Shares | Sole | 2025-07-08 | |
| 2025-03-31 | $1,946,188 | 76,803 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $1,934,488 | 72,917 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $2,032,051 | 70,216 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,007,565 | 71,750 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $1,947,550 | 70,182 | Shares | Sole | 2024-04-08 | |
| 2023-12-31 | $1,927,375 | 66,946 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,350,061 | 70,849 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,566,646 | 69,974 | Shares | Sole | 2023-07-18 | |
| 2023-03-31 | $2,818,749 | 69,087 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $3,402,489 | 66,403 | Shares | Sole | 2023-01-05 | |
| 2022-09-30 | $3,100,658 | 70,856 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $3,667,740 | 69,955 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $3,598,636 | 69,512 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $3,879,112 | 65,692 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $2,849,369 | 66,249 | Shares | Sole | 2021-10-14 | |
| 2021-06-30 | $2,563,178 | 65,454 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $2,177,169 | 60,093 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $2,014,353 | 54,723 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $1,946,749 | 53,045 | Shares | Sole | 2020-10-15 | |
| 2020-06-30 | $1,715,476 | 52,461 | Shares | Sole | 2020-07-21 | |
| 2020-03-31 | $1,717,057 | 52,606 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||